Group 1 - The company, Kingway Medical (08143), reported a revenue of HKD 10.5 million for the six months ending September 30, 2025, representing a year-on-year increase of 0.62% [1] - The company experienced a loss attributable to shareholders of HKD 2.671 million, marking a shift from profit to loss compared to the previous year [1] - The loss per share was reported at HKD 0.237 [1]

华检医疗(01931)发布公告，于2025年11月28日，该公司斥资772.36万港元回购118.7万股股份，每股回 购价格为6.37-6.53港元。 ...

格隆汇11月28日丨金陵药业(000919.SZ)公布，控股子公司南京梅山医院有限责任公司（简称"南京梅山 医院"或"医院"）为更好地满足辐射区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与 服务能力，拟投资89,329.63万元（最终以实际投资金额为准）实施医院改扩建项目。项目建设内容：主 要包括拆除工程、改造工程、新建工程、室外工程等土建安装工程，以及医疗专项和医疗设备购置。主 体工程为新建的门急诊医技病房综合楼，该工程共计地上12层，地下2层，主要功能为门诊、急诊、医 技及病房等。 ...

Core Viewpoint - Perfect Medical (01830) reported a significant decline in revenue and profit for the six months ending September 30, 2025, indicating potential challenges in its business operations [1] Financial Performance - Revenue decreased by 21.7% year-on-year to HKD 486 million [1] - Profit attributable to equity holders fell by 32.7% to HKD 94.8 million [1] - Basic earnings per share were HKD 0.075 [1] - The company proposed an interim dividend of HKD 0.076 per share [1]

Core Viewpoint - Meili Tianyuan Healthcare (02373) has repurchased shares, indicating management's confidence in the company's long-term value and business prospects [1] Summary by Sections Share Repurchase Details - The company repurchased 80,000 shares on November 28, 2025, for approximately HKD 2.0074 million, at an average price of HKD 25.09 per share [1] - From October 15, 2025, to the date of the announcement, the total shares repurchased amounted to 695,000, with a total cost of approximately HKD 20.6924 million [1] Management's Perspective - The board believes that the current share price does not reflect the intrinsic value of the shares and the actual business outlook of the company [1] - The share repurchase is seen as a demonstration of management's strong confidence in the company's long-term value, which is expected to enhance the group's market value and shareholder return capabilities [1] - The board asserts that the repurchase aligns with the overall interests of the company and its shareholders [1]

每经AI快讯，金陵药业（SZ 000919，收盘价：7.26元）11月28日晚间发布公告称，公司第九届第二十 二次董事会会议于2025年11月28日以现场会议和通讯会议相结合的方式召开。会议审议了《关于提请召 开2025年第四次临时股东会的议案》等文件。 每经头条（nbdtoutiao）——已有75人遇难，1名死者为消防员，还有10名消防员受伤！记者现场直击香 港大埔火灾：燃烧的宏福苑，五级大火的五个谜团 2025年1至6月份，金陵药业的营业收入构成为：医疗收入占比50.44%，药品生产与销售占比48.5%，其 他行业占比1.06%。 截至发稿，金陵药业市值为45亿元。 （记者 张明双） ...

证券之星消息，截至2025年11月28日收盘，通策医疗(600763)报收于42.05元，上涨0.69%，换手率 0.83%，成交量3.72万手，成交额1.56亿元。 11月28日的资金流向数据方面，主力资金净流出903.7万元，占总成交额5.79%，游资资金净流入425.74 万元，占总成交额2.73%，散户资金净流入477.96万元，占总成交额3.06%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净占比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-11-28 | 42.05 | 0.69% | -903.70万 | -5.79% | 425.74万 | 2.73% | 477.96万 | 3.06% | | 2025-11-27 | 41.76 | -0.33% | -1731.26万 | -10.08% | 838.90万 | 4.88% | 892.36万 | 5.19% | | 2025-11-26 | 41.90 | ...

希玛医疗(03309)发布公告，于2025年11月28日，该公司斥资38.13万港元回购22万股股份，每股回购价 格为1.73-1.74港元。 ...

智通财经APP讯，希玛医疗(03309)发布公告，于2025年11月28日，该公司斥资38.13万港元回购22万股 股份，每股回购价格为1.73-1.74港元。 ...

Core Viewpoint - The company, Guoshengtang (02273), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will spend HKD 8.5854 million to repurchase 287,600 shares [1] - The buyback price per share ranges from HKD 29.62 to HKD 30 [1]